<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04644562</url>
  </required_header>
  <id_info>
    <org_study_id>FMBSUREC/05072020/Abd El Badei</org_study_id>
    <nct_id>NCT04644562</nct_id>
  </id_info>
  <brief_title>Ultrasound-guided Lumbar Erector Spinae Plane Block in Patients Undergoing Lower Limb Vascular Surgery</brief_title>
  <official_title>The Anaesthetic and Analgesic Efficacy of Ultrasound-guided Lumbar Erector Spinae Plane Block in Patients Undergoing Lower Limb Vascular Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beni-Suef University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beni-Suef University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      the investigatots hypothesized that by injection a larger volume and higher concentration of&#xD;
      local anesthetic in lumbar erector spinae plane block could result in successful anesthesia&#xD;
      in patient undergoing lower limb vascular surgery.&#xD;
&#xD;
      ultrasound-guided lumbar erector spinae plane block in patient undergoing lower limb vascular&#xD;
      surgery with higher concentration of local anesthetic to asses it is efficacy as a sole&#xD;
      anesthetic technique, it is safety and efficacy in maintaining intraoperative hemodynamics,&#xD;
      intra and postoperative pain control .&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The patients will placed in lateral position. After aseptic preparation of the skin and&#xD;
      probe, a high-frequency linear ultrasound transducer will move about 3 cm laterally on the&#xD;
      parasagittal plane to visualize the transverse process of the (L2) vertebra. An 18-guage&#xD;
      tuohy needle will be approached in-plane lateral to medial. When the needle initially touched&#xD;
      the transverse process of L3 vertebrae, the needle will be gently withdrawn and&#xD;
      hydrodissection of the plane achieved, lifting the erector spinae muscle. A 20-guage catheter&#xD;
      will be introduced through the needle and total length inserted will be 3 cm more than the&#xD;
      tip of needle (. 25 mL of 0.5% bupivacaine ( in increments slowly after negative aspiration&#xD;
      will be injected in the interfascial plane observing the anesthetic spread.&#xD;
&#xD;
      Sensory and motor block will be evaluated and surgery will begin only after adequate block ,&#xD;
      if failed, general anesthesia will induced by injecting 1.5-2 mg/kg propofol, 2 μg/kg&#xD;
      fentanyl &amp; 0.5 mg/kg atracurium.&#xD;
&#xD;
      The patients will be ventilated via face mask with 100 % oxygen at a rate of 4 L/min and&#xD;
      isoflurane 1.2 %. After 3 minutes, the patients will be intubated using appropriate sized&#xD;
      cuffed oral tube lubricated with lidocaine jelly 2 % .&#xD;
&#xD;
      Maintenance of anesthesia will done using isoflurane 1.2 % in 100 % O2. Muscle relaxation&#xD;
      will be continued by atracurium 0.1 mg/kg every 20 min. All patients will be mechanically&#xD;
      ventilated to maintain end-tidal carbon dioxide between 35-40 mmHg. For 5 minutes, no&#xD;
      surgical interventions will be allowed in the subjects to assess target blood pressure.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">November 20, 2020</start_date>
  <completion_date type="Anticipated">January 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>motor block block level</measure>
    <time_frame>baseline, pre-intervention/procedure/surgery</time_frame>
    <description>motor power</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">5</enrollment>
  <condition>Anesthesia, Local</condition>
  <arm_group>
    <arm_group_label>patients undergoing Lower Limb vascular Surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ultrasound-guided lumbar Erector Spinae plane block in patients undergoing Lower Limb vascular Surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Erector Spinae plane block</intervention_name>
    <description>Ultrasound-guided lumbar Erector Spinae plane block in patients undergoing Lower Limb vascular Surgery</description>
    <arm_group_label>patients undergoing Lower Limb vascular Surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - ASA II and III male and female patients undergoing lower limb vascular surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindications for regional blocks (eg. Patient refusal Infection at the injection&#xD;
             site, coagulopathy)&#xD;
&#xD;
          -  allergic reaction to drugs.&#xD;
&#xD;
          -  opium addiction, any drug or substance abuse and chronic treatment with opium,&#xD;
             non-steroidal anti-inflammatory drugs&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>doaa rashwan, md</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beni-Suef University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>doaa rashwan, md</last_name>
    <phone>00201011270763</phone>
    <email>doaa_rashwan@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Benisuef univercity</name>
      <address>
        <city>Banī Suwayf,</city>
        <state>Benisuef</state>
        <zip>62511</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Doaa Rashwan, MD</last_name>
      <phone>01011270763</phone>
      <email>doaa_rashwan@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Samaa Rashwan, MD Rashwan, MD</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>July 17, 2020</study_first_submitted>
  <study_first_submitted_qc>November 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 25, 2020</study_first_posted>
  <last_update_submitted>November 19, 2020</last_update_submitted>
  <last_update_submitted_qc>November 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beni-Suef University</investigator_affiliation>
    <investigator_full_name>doaa rashwan</investigator_full_name>
    <investigator_title>Assistant professor Doaa Rashwan</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

